Skip to main content
. 2016 Apr 20;12(1):123–134. doi: 10.3892/etm.2016.3273

Table IV.

Results of the chromosomal aberration assay.

Aberrant metaphases Total aberrations


Treatment conditions Dose (µg/ml) With gaps Without gaps With gaps Without gaps PP ER
Treatment time 6 h, recovery time 18 h, with S9
  Vehicle controla 0.50±0.58 0.00±0.00 1.25±0.96 0.75±0.96 0.50±0.58 0.25±0.50
  PR extract 0.5 0.25±0.50 0.00±0.00 1.25±0.50 1.00±0.00 0.50±0.58 0.50±0.58
5 0.75±0.50 0.00±0.00 1.00±0.82 0.25±0.50 0.25±0.50 0.00±0.00
50 0.75±0.50 0.00±0.00 1.75±0.50 1.00±0.00 0.50±0.58 0.50±0.58
500 0.25±0.50 0.00±0.00 0.50±0.58 0.25±0.50 0.25±0.50 0.00±0.00
1,000 0.50±0.58 0.00±0.00 1.50±1.00 1.00±0.82 0.75±0.50 0.25±0.50
5,000 0.50±0.58 0.00±0.00 1.00±0.00 0.50±0.58 0.25±0.50 0.25±0.50
  Cyclophosphamide 6 26.75±3.30b 23.50±2.38b 28.75±3.50b 25.50±2.65b 0.75±0.50 1.25±0.96
Treatment time 6 h, recovery time 18 h, without S9
Vehicle controla 1.00±0.82 0.25±0.50 2.00±1.41 1.25±0.96 0.50±0.58 0.50±0.58
PR extract 0.5 0.25±0.50 0.00±0.00 1.00±0.82 0.75±0.50 0.25±0.50 0.50±0.58
5 0.50±0.58 0.00±0.00 1.50±0.58 1.00±0.82 0.50±0.58 0.50±0.58
50 1.00±0.82 0.25±0.50 1.50±1.29 0.75±0.96 0.00±0.00 0.50±0.58
500 0.25±0.50 0.00±0.00 0.75±0.50 0.50±0.58 0.25±0.50 0.25±0.50
1,000 0.75±0.96 0.25±0.50 1.50±1.29 1.00±0.82 0.50±0.58 0.25±0.50
5,000 0.75±0.96 0.25±0.50 1.25±0.96 0.75±0.50 0.25±0.50 0.25±0.50
Ethylmethanesulfonate 800 38.50±6.14b 32.00±4.97b 39.75±6.55b 33.25±5.38b 0.50±0.58 0.75±0.50
Treatment time 24 h, recovery time 0 h, without S9
  Vehicle controla 1.75±1.71 0.75±0.96 2.75±1.71 1.75±0.96 0.25±0.50 0.50±0.58
  PR extract 0.5 2.25±1.26 0.75±0.96 3.25±2.22 1.75±1.71 0.00±0.00 0.50±0.58
5 2.00±1.63 1.00±0.82 3.25±2.22 2.25±1.50 0.50±0.58 0.50±0.58
50 2.00±1.83 0.75±0.96 3.25±0.96 2.00±0.82 0.50±0.58 0.25±0.50
500 1.00±0.82 0.25±0.50 1.25±0.50 0.50±0.58 0.25±0.50 0.00±0.00
1,000 1.25±1.89 0.50±1.00 3.00±2.83 2.25±2.22 0.50±1.00 0.75±0.96
5,000 1.00±0.82 0.50±1.00 2.00±0.82 1.50±0.58 0.25±0.50 0.25±0.50
  Ethylmethanesulfonate 600 56.25±11.41b 48.25±10.21b 59.25±13.57b 51.25±12.50b 0.75±0.50 1.00±0.82

Values are expressed as mean ± standard deviation of 100 metaphase cells from quadruple flasks/dose. PR, Persicariae Rhizoma; PP, polyploid; ER, endoreduplication.

a

Vehicle control, sterile distilled water.

b

P<0.05 vs. vehicle control by Mann Whitney U test.